ESR1 and breast carcinoma: By interaction with transcription factors and chromatin modifiers such as ER-alpha and histone deacetylase inhibitor HDAC1/245, 46, MIER1-alpha inhibits estrogen dependent growth and lack nucleus internalization during breast cancer progression47.